Phong Tran, USNR (President and CEO), brings 32 years of industry experience, having contributed to 11 Investigational New Drug (IND) applications and 4 FDA-approved drugs. He has played a key role in successful strategic alliances and partnerships with Sanofi-Aventis, AstraZeneca, JNJ, Wyeth-Ayerst, Schering-Plough, Medline E&R, and Konica-Minolta Healthcare Americas. Mr. Tran has held increasing roles at large CRO, pharmaceutical and medical technology companies, and biotech startups. He served as Interim CEO at Bound Therapeutics, Senior Director of In-vivo Pharmacology and RNA Subject-Matter-Expert at WuXi AppTec, Founding Director of BioPharmaceutical Research Business Development at Alfa Wasserman, and Senior In-vivo Pharmacologist at Regulus Therapeutics and Ionis Pharmaceuticals. Additionally, he was a Research Scientist at Pfizer Global Research and Development, and a Senior Research Associate at Arena Pharmaceuticals, Cortex Pharmaceuticals, and a Staff Research Associate at the University of California Irvine School of Medicine Department of Pharmacology. In addition, Mr. Tran previously served in the United States Navy as a Preventive Medicine Officer and has been an industry advisor to several biotech startups and life science consulting firms.